Chaihu Shugan San exerts antidepressant effects in female mice by suppressing hippocampal IL-6 and activating the cAMP-CaMKII-BDNF pathway
Journal of Ethnopharmacology · 2026-06 · 364 · 121502
DOI: 10.1016/j.jep.2026.121502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2026-06. Verfasst von Xiangfei Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Affiliated Brain Hospital, Guangzhou Medical University, No. 36, Mingxin Road, Guangzhou, Guangdong, Chin…. Hauptthemen laut MEDLINE: Antidepressive Agents, Hippocampus, Depression, Plant Extracts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Chaihu Shugan San (CSS), a classical Traditional Chinese Medicine (TCM) formula, was first recorded in Jingyue Quanshu (1624 AD) for treating "liver qi stagnation" (Yu Syndrome), a TCM diagnostic pattern analogous to modern mood disorders. Although CSS has been prescribed for emotional distress, irritability, and depressive symptoms for centuries, the neurobiological mechanisms underlying its antidepressant efficacy, particularly in the context of gender-specific pathology, remain poorly revealed. AIM OF THE STUDY: The present study probed the antidepressant effects of CSS in female mice, while elucidating the underlying molecular mechanisms involving hippocampal neuroinflammation and neuroplasticity. We hypothesized that CSS reverses chronic stress-induced depressive phenotypes by suppressing interleukin-6 (IL-6), which in turn facilitates cAMP-CaMKII-BDNF signaling pathway in the hippocampus. MATERIALS AND METHODS: Adult female C57BL/6J mice were subjected to a 5-week chronic unpredictable mild stress (CUMS) regimen to evoke depressive-like behaviors. During the final 2 weeks of the regimen, CSS was administered intragastrically at 0.5, 1.0, or 1.5 g/kg, with fluoxetine (10 mg/kg) as the positive control. Behavioral assessments included forced swimming test (FST), sucrose preference test (SPT), open field test (OFT), and tail suspension test (TST). Hippocampal IL-6, cAMP, CaMKII, and BDNF levels were quantified by ELISA. Mechanistic validation employed acute hippocampal microinjection of recombinant IL-6 (1 μg/site) and systemic administration of the CaMKII inhibitor KN-93 (6 mg/kg). Chemical constituents were identified by UHPLC-QTOF MS. RESULTS: CSS alleviated CUMS-induced depressive-like behaviors in a dose-dependent manner, cutting down immobility time in TST/FST and reinstating sucrose preference, similar to the action of fluoxetine. CSS significantly suppressed hippocampal IL-6 while upregulating cAMP, CaMKII activity, and BDNF expression. Acute IL-6 elevation completely abolished both the behavioral antidepressant effects and molecular actions of CSS. Pharmacological inhibition of CaMKII blocked CSS-induced behavioral improvement and its upregulation of cAMP-BDNF signaling, without affecting basal behaviors. CSS exhibited no anxiogenic or locomotor side effects. CONCLUSION: CSS exerts potent antidepressant effects in female mice through coordinated suppression of hippocampal IL-6 and activation of the cAMP-CaMKII-BDNF neuroplasticity-related pathway, with CaMKII playing a critical role in this process. These findings offer scientific evidence for the traditional use of CSS in addressing emotional disorders and highlight its therapeutic potential as a multi-targeted, anti-inflammatory botanical medicine for female-specific depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, Affiliated Brain Hospital, Guangzhou Medical University, No. 36, Mingxin Road, Guangzhou, Guangdong, China.
- Department of General Surgery, Nanjing Drum Tower Hospital, Drum Tower Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
- Jiangsu Food & Pharmaceutical Science College, Jiangsu, China.
- School of Elderly Care Services Management, Nanjing University of Chinese Medicine, Nanjing, China.
- Yancheng Key Laboratory of Molecular Epigenetics, Yancheng Medical Research Center, Nanjing University Medical School, The First People's Hospital of Yancheng, Yancheng, Jiangsu, China.
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Luo, B., Gao, L., Zhang, L., Li, X., Lu, Q., Zhang, J., Zhu, J., Qian, J., Shan, C., Luo, T., Liang, Y. Y., Liu, Y., & Han, W. (2026). Chaihu Shugan San exerts antidepressant effects in female mice by suppressing hippocampal IL-6 and activating the cAMP-CaMKII-BDNF pathway. Journal of Ethnopharmacology, 364, 121502. https://doi.org/10.1016/j.jep.2026.121502
Vancouver
Liu X, Luo B, Gao L, Zhang L, Li X, Lu Q, et al. Chaihu Shugan San exerts antidepressant effects in female mice by suppressing hippocampal IL-6 and activating the cAMP-CaMKII-BDNF pathway. Journal of Ethnopharmacology. 2026;364:121502. doi:10.1016/j.jep.2026.121502
BibTeX
@article{Liu2026,
author = {Liu, Xiangfei and Luo, Banxin and Gao, Li and Zhang, Lida and Li, Xiao and Lu, Qiuling and Zhang, Junru and Zhu, Junji and Qian, Jiacheng and Shan, Chenxiao and Luo, Tong and Liang, Yannis Yan and Liu, Yaping and Han, Wei},
title = {Chaihu Shugan San exerts antidepressant effects in female mice by suppressing hippocampal IL-6 and activating the cAMP-CaMKII-BDNF pathway},
journal = {Journal of Ethnopharmacology},
year = {2026},
volume = {364},
pages = {121502},
doi = {10.1016/j.jep.2026.121502}
}
EUVIMED